首页> 外文期刊>Expert review of clinical pharmacology >Non-benzodiazepine hypnotics and older adults: What are we learning about zolpidem?
【24h】

Non-benzodiazepine hypnotics and older adults: What are we learning about zolpidem?

机译:非苯二氮卓类催眠药和老年人:我们对唑吡坦了解什么?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Zolpidem and other non-benzodiazepine (BZD) hypnotic agents have become preferred drugs to manage insomnia. They are widely used among older adults because of perceived improved safety profiles compared with traditional BZDs. Accumulating data in recent years in patients over the age of 65, however, shed light on possible safety concerns of these medications and zolpidem specifically. Recent information regarding potential for excessive blood concentrations, effects on balance and memory and fracture risk data briefly is described. Clinicians should be aware of these most recent data. Non-drug therapies, as recommended in clinical guidelines, should be fully utilized for managing insomnia. Until better studies or pharmacovigilance data become available to guide patient selection for prescribing zolpidem and other non-BZDs, judicious use of these hypnotic agents in older adults is warranted.
机译:唑吡坦和其他非苯二氮杂(BZD)催眠药已成为治疗失眠的首选药物。由于与传统BZD相比安全性得到改善,因此它们在老年人中得到广泛使用。然而,近年来积累的65岁以上患者的数据揭示了这些药物和唑吡坦的安全性问题。简要介绍了有关血药浓度过高,对平衡和记忆力的影响以及骨折风险数据的最新信息。临床医生应注意这些最新数据。根据临床指南的建议,应充分利用非药物疗法来治疗失眠。在获得更好的研究或药物警戒性数据以指导患者选择唑吡坦和其他非BZD的处方之前,必须明智地在老年人中使用这些催眠药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号